Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve 1. To Consider and Approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Astal Laboratories Ltd has informed BSE that a meeting of its Board of Directors is scheduled for Saturday, May 30, 2026 at its corporate office in Hyderabad. The meeting will consider and approve the audited standalone and consolidated financial results for Q4 and the year ended March 31, 2026, along with the limited review report from auditors. Additionally, the board will consider the audited standalone and consolidated financial statements for FY 2025-26 and appoint an Internal Auditor for FY 2026-27. The trading window for designated persons has been closed from April 1, 2026 and will remain closed until 48 hours after the board meeting concludes.
This is a routine board meeting intimation indicating upcoming Q4 and full-year FY26 results approval. The closure of the trading window suggests results may be material. Shareholders should expect the audited financial results to be released shortly after May 30, 2026.